SourceOne Stock Info  Your one source site for stock research




Company Website

Investor Relations



What’s the buzz—

message boards


Market Watch

Money Central

Raging Bull

Board Central









Gilead Sciences



Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases globally. Gilead Sciences’ products, of which eight have been approved, include Viread, Emtriva, Truvada, DaunoXome, Vistide, AmBisome, Hepsera, Macugen and Tamiflu. In December 2004, Gilead entered into a collaboration agreement with Bristol-Myers Squibb to develop and commercialize the fixed-dose combination of Gilead's Truvada and BMS's Sustiva in the United States. Structured as a joint venture, Gilead and BMS formed the limited liability company, Bristol-Myers Squibb & Gilead Sciences, LLC. If approved, the new product would be a complete highly active antiretroviral therapy treatment regimen for human immunodeficiency virus available in a fixed-dose combination taken once daily.


Stock Quotes and Other Information





Silicon Investor



Market Watch

Clear Station



SourceOne Message Board


Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name














S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35